Utah Medical Products, Inc. carries a market capitalization of 225.14M, placing it among publicly traded companies globally. Its enterprise value stands at 219.63M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 225.14M |
| Enterprise Value | 219.63M |
Utah Medical Products, Inc. currently has 3.18M shares outstanding.
| Shares Outstanding | 3.18M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Utah Medical Products, Inc. trades at a trailing price-to-earnings ratio of 28.21.
| PE Ratio | 28.21 |
| PS Ratio | 7.98 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | 20.80 |
| P/OCF Ratio | 21.03 |
On an enterprise value basis, Utah Medical Products, Inc. trades at an EV/EBITDA multiple of 21.38 and an EV/FCF ratio of 20.73. The EV/Sales ratio of 7.96 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 27.26 provides insight into valuation relative to core operating earnings.
| EV / Sales | 7.96 |
| EV / EBITDA | 21.38 |
| EV / EBIT | 27.26 |
| EV / FCF | 20.73 |
Utah Medical Products, Inc. maintains a current ratio of 98.32, meaning it holds 98.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 98.32 |
| Quick Ratio | 89.56 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Utah Medical Products, Inc. posts a return on equity of 13.27 and a return on invested capital of 11.12.
| Return on Equity (ROE) | 13.27 |
| Return on Assets (ROA) | 12.92 |
| Return on Invested Capital (ROIC) | 11.12 |
| Return on Capital Employed (ROCE) | 13.25 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.78 |
Over the trailing twelve months, Utah Medical Products, Inc. has paid 1.80M in income taxes, reflecting an effective tax rate of 18.71.
| Income Tax | 1.80M |
| Effective Tax Rate | 18.71 |
Utah Medical Products, Inc.'s stock has gained approximately 15.80413% over the past 52 weeks. The 50-day moving average sits at 70.48, while the 200-day moving average is 64.67.
| Beta (5Y) | N/A |
| 52-Week Price Change | 15.80413% |
| 50-Day Moving Average | 70.48 |
| 200-Day Moving Average | 64.67 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Utah Medical Products, Inc. generated 27.58M in revenue and converted that into 7.80M in net income, yielding earnings per share of 2.44. EBITDA reached 10.28M, while operating income came in at 8.06M.
| Revenue | 27.58M |
| Gross Profit | 16.15M |
| Operating Income | 8.06M |
| Pretax Income | 9.60M |
| Net Income | 7.80M |
| EBITDA | 10.28M |
| EBIT | 8.06M |
| Earnings Per Share (EPS) | 2.44 |
Utah Medical Products, Inc. produced 10.46M in operating cash flow over the past twelve months. After subtracting -130,000.00 in capital expenditures, free cash flow totaled 10.33M - equivalent to 3.24 per share.
| Operating Cash Flow | 10.46M |
| Capital Expenditures | -130,000.00 |
| Free Cash Flow | 10.33M |
| FCF Per Share | 3.24 |
Utah Medical Products, Inc. operates with a gross margin of 58.56, reflecting its pricing power and cost economics. The operating margin of 29.22 and net profit margin of 28.29 provide insight into operational efficiency.
| Gross Margin | 58.56 |
| Operating Margin | 29.22 |
| Pretax Margin | 34.80 |
| Profit Margin | 28.29 |
| EBITDA Margin | 37.26 |
The company's payout ratio of 37.87 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.93 |
| Dividend Yield | N/A |
| Payout Ratio | 37.87 |
| Shareholder Yield | 2.15 |
| FCF Yield | 4.81 |
Utah Medical Products, Inc.'s most recent stock split took place on March 22, 1993 with a 2:3 split ratio.
| Last Split Date | 3/22/1993 |
| Split Ratio | 2:3 |
Utah Medical Products, Inc. posts an Altman Z-Score of 105.05, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 105.05 |